Empyrean Medical Systems, a leading Florida-based radiation oncology company, and Hamilton Reserve Bank (HRB), the largest global bank headquartered in the Caribbean with more than $4.2 billion in assets, have completed a strategic investment agreement to support Empyrean's mission to disrupt radiation oncology and launch first-in-class technologies to market in 2026. The Bank serves clients from 150 countries, operating in 15 languages and 126 currencies.

"Hamilton Reserve Bank is now an institutional shareholder of Empyrean Medical Systems," said Brittney Lovely, Managing Director, North America, Hamilton Reserve Bank. "The Bank has made an equity investment and will arrange a credit line of up to $20 million, subject to customary terms and conditions, to support Empyrean's product sales beginning in 2026. We believe Empyrean is well-positioned for breakthrough successes in the oncology industry." 

Kal Fishman, Chairman and CEO of Empyrean Medical Systems, commented: "We are pleased that Hamilton Reserve Bank has become a significant shareholder in Empyrean Medical Systems and an institutional backer of our mission to change radiation oncology for good. HRB's strategic investment will accelerate our disruptive product line market deployment, supporting the anticipated commencement of patient treatments in collaboration with MD Anderson Cancer Centre and other leading luminary cancer centres around the world, subject to applicable regulatory clearances."

"With Empyrean Medical Systems, the world finally has a highly effective, first-in-class technology to treat cancer and save more lives," said Hamilton Reserve Bank General Counsel Sebastian Ambrose, who has spearheaded the investment. "Hamilton Reserve Bank is pleased to join other world-renowned institutions such as MD Anderson Cancer Centre, which owns 15 per cent of Empyrean and Mayo Clinic as co-shareholders in Empyrean Medical Systems."